ArticleActa pharmacologica Sinica2025

Receptor tyrosine kinase inhibitor tivozanib regulates cell state plasticity and restores MITF dependency in BRAF wild-type melanoma.

Yan-Ni Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.